Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Avdl crawled time : 13:03 save search
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
Published: 2021-03-01 (Crawled : 13:03) - globenewswire.com
AVDL | $18.075 4.48% 4.29% 990K
|
Health Technology
|
| O: 0.75%
H: 4.57%
C: 2.22%
new drug treatment fda drug ft218 fda acceptance narcolepsy
Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
Published: 2021-02-17 (Crawled : 13:03) - globenewswire.com
AVDL | $18.075 4.48% 4.29% 990K
|
Health Technology
|
| O: -0.12%
H: 3.37%
C: 2.67%
ft218 commercialization
Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-10 (Crawled : 13:03) - globenewswire.com
AVDL | $18.075 4.48% 4.29% 990K
|
Health Technology
|
| O: 1.4%
H: 2.09%
C: -0.46%
svb leerink global
Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index
Published: 2020-12-15 (Crawled : 13:03) - globenewswire.com
AVDL | $18.075 4.48% 4.29% 990K
|
Health Technology
|
| O: 0.27%
H: 8.9%
C: 5.58%
biotech nasdaq
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.